Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/RAKOVINA-THERAPEUTICS-INC-121074531/news/Rakovina-Therapeutics-prasentiert-die-Bewertung-einer-neuen-Klasse-bifunktionaler-DNA-alkylierender-40042929/?utm_source=whatsapp&utm_medium=social&utm_campaign=share